Çiğdem Karaca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Çiğdem Karaca has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
N. Er
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hacettepe University, Ankara, Turkey
3 shared publications- Nuray Er
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hacettepe University, Ankara, Turkey
3 shared publications O.T. Köseoğlu
3 shared publicationsA Aktas
DDS, PhD, Hacettepe University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Ankara, Turkey
1 shared publicationA Okten
1 shared publicationA Usubutun
MD, PhD, Hacettepe University, Faculty of Medicine, Department of Pathology, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 16 June 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
The efficacy of blood-derived growth factor source compared to bone-derived growth factor source on bone regeneration in critical-sized rabbit calvarial bone defects
The growth factor sources used in alveolar bone regeneration should be practical and at a level that provides maximum benefit and cost effectiveness. Autologous growth factors are easy and practical to obtain in clinical practice, but their effectiveness in bone regeneration should be assessed in vivo studies. The hypothesis of this study was that the contribution of bone derived growth factors source to bone formation is greater than that of blood-derived growth factor source. Thirty male New Zealand rabbits were utilized in the experiment. Four defects of 8 mm were organized in the calvarium of each rabbit, and four treatment procedures were implemented: (1) empty defect, (2) autograft and xenograft (3) autograft+xenograft functionalized with growth factors released from autograft (4) autograft+ xenograft with injectable platelet rich fibrin (i-PRF). Rabbits were sacrificed at 4, 8 and 12 weeks of healing. Micro-computed tomography and histomorphometrically analyses were performed. The statistical difference was evaluated using two-way repeated measures analysis of variance. The significance level was set as p < 0.05. The autograft+xenograft, autograft+xenograft functionalized with growth factors released from autograft and autograft+ xenograft with i-PRF provided comparable bone formation at 4 and 8 weeks. The autograft+xenograft with i-PRF revealed significantly higher new bone formation at 12 weeks compared to that of autograft+xenograft group. (p = 0.016) There was no difference in the new bone formation between autograft+xenograft with i-PRF and autograft+xenograft functionalized with growth factors groups. (p = 0.75) The residual graft remained comparable among treatment groups at all time points. (p = 0.05) CONCLUSIONS: The composite graft contains growth factors obtained from i-PRF showed better new bone formation. Both blood and bone-derived growth factor sources can be utilized to functionalize the osteoconductive graft materials.
- 16 June 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessThe efficacy of blood-derived growth factor source compared to bone-derived growth factor source on bone regeneration in critical-sized rabbit calvarial bone defects
The growth factor sources used in alveolar bone regeneration should be practical and at a level that provides maximum benefit and cost effectiveness. Autologous growth factors are easy and practical to obtain in clinical practice, but their effectiveness in bone regeneration should be assessed in vivo studies. The hypothesis of this study was that the contribution of bone derived growth factors source to bone formation is greater than that of blood-derived growth factor source. Thirty male New Zealand rabbits were utilized in the experiment. Four defects of 8 mm were organized in the calvarium of each rabbit, and four treatment procedures were implemented: (1) empty defect, (2) autograft and xenograft (3) autograft+xenograft functionalized with growth factors released from autograft (4) autograft+ xenograft with injectable platelet rich fibrin (i-PRF). Rabbits were sacrificed at 4, 8 and 12 weeks of healing. Micro-computed tomography and histomorphometrically analyses were performed. The statistical difference was evaluated using two-way repeated measures analysis of variance. The significance level was set as p < 0.05. The autograft+xenograft, autograft+xenograft functionalized with growth factors released from autograft and autograft+ xenograft with i-PRF provided comparable bone formation at 4 and 8 weeks. The autograft+xenograft with i-PRF revealed significantly higher new bone formation at 12 weeks compared to that of autograft+xenograft group. (p = 0.016) There was no difference in the new bone formation between autograft+xenograft with i-PRF and autograft+xenograft functionalized with growth factors groups. (p = 0.75) The residual graft remained comparable among treatment groups at all time points. (p = 0.05) CONCLUSIONS: The composite graft contains growth factors obtained from i-PRF showed better new bone formation. Both blood and bone-derived growth factor sources can be utilized to functionalize the osteoconductive graft materials.
- 20 October 2023
- Published by Quintessence Publishing in The International Journal of Oral and Maxillofacial Implants
- Vol. 39 (4) , 585-594
Effects of Stabilization of the Sinus Membrane by Dental Implant Insertion and Membrane Suturing on Endo-Sinus Bone Gain in Cases of Lateral Sinus Lift Performed Without Graft Material
Purpose: The aim of this study was to investigate the effects of membrane stabilization by suturing the sinus membrane and dental implant insertion on endo-sinus bone formation in lateral sinus lifting performed without grafting. Materials and Methods: Maxillary sinus lift surgery using ...
- 20 October 2023
- Published by Quintessence Publishing in The International Journal of Oral and Maxillofacial Implants
- Vol. 39 (4) , 585-594
Effects of Stabilization of the Sinus Membrane by Dental Implant Insertion and Membrane Suturing on Endo-Sinus Bone Gain in Cases of Lateral Sinus Lift Performed Without Graft Material
Purpose: The aim of this study was to investigate the effects of membrane stabilization by suturing the sinus membrane and dental implant insertion on endo-sinus bone formation in lateral sinus lifting performed without grafting. Materials and Methods: Maxillary sinus lift surgery using ...
- Open Access
- 30 April 2023
- Published by The Korean Association of Oral and Maxillofacial Surgeons in Journal of the Korean Association of Oral and Maxillofacial Surgeons
- Vol. 49 (2) , 68-74
The effect of drug holiday before tooth extraction on the development of medication-related osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates
Çiğdem Karaca, Göknur Topaloğlu-Yasan, Selen Adiloğlu, Ecem Usman. JKAOMS 2023;49:68-74. https://doi.org/10.5125/jkaoms.2023.49.2.68
- 30 April 2023
- Published by The Korean Association of Oral and Maxillofacial Surgeons in Journal of the Korean Association of Oral and Maxillofacial Surgeons
- Vol. 49 (2) , 68-74
Open AccessThe effect of drug holiday before tooth extraction on the development of medication-related osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates
Çiğdem Karaca, Göknur Topaloğlu-Yasan, Selen Adiloğlu, Ecem Usman. JKAOMS 2023;49:68-74. https://doi.org/10.5125/jkaoms.2023.49.2.68
- 1 February 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (2) , 251-257
The effect of residual bone height and membrane thickness on sinus membrane perforation in crestal sinus grafting: A prospective clinical study
- 1 February 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (2) , 251-257
The effect of residual bone height and membrane thickness on sinus membrane perforation in crestal sinus grafting: A prospective clinical study
- Open Access
- 16 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
A small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition
Hepatocellular carcinoma (HCC) ranks as the fifth most common and the second deadliest cancer worldwide. HCC is extremely resistant to the conventional chemotherapeutics. Hence, it is vital to develop new treatment options. Chalcones were previously shown to have anticancer activities in other cancer types. In this study, 11 chalcones along with quercetin, papaverin, catechin, Sorafenib and 5FU were analyzed for their bioactivities on 6 HCC cell lines and on dental pulp stem cells (DPSC) which differentiates into hepatocytes, and is used as a model for untransformed control cells. 3 of the chalcones (1, 9 and 11) were selected for further investigation due to their high cytotoxicity against liver cancer cells and compared to the other clinically established compounds. Chalcones did not show significant bioactivity ( $$\hbox {IC}_{50}>20\upmu \hbox {M}$$ ) on dental pulp stem cells. Cell cycle analysis revealed that these 3 chalcone-molecules induced SubG1/G1 arrest. Akt protein phosphorylation was inhibited by these molecules in PTEN deficient, drug resistant, mesenchymal like Mahlavu cells leading to the activation of p21 and the inhibition of NF $$ \kappa $$ B-p65 transcription factor. Hence the chalcones induced apoptotic cell death pathway through NF $$ \kappa $$ B-p65 inhibition. On the other hand, these molecules triggered p21 dependent activation of Rb protein and thereby inhibition of cell cycle and cell growth in liver cancer cells. Involvement of PI3K/Akt pathway hyperactivation was previously described in survival of liver cancer cells as carcinogenic event. Therefore, our results indicated that these chalcones can be considered as candidates for liver cancer therapeutics particularly when PI3K/Akt pathway involved in tumor development.- 16 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Open AccessA small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition
Hepatocellular carcinoma (HCC) ranks as the fifth most common and the second deadliest cancer worldwide. HCC is extremely resistant to the conventional chemotherapeutics. Hence, it is vital to develop new treatment options. Chalcones were previously shown to have anticancer activities in other cancer types. In this study, 11 chalcones along with quercetin, papaverin, catechin, Sorafenib and 5FU were analyzed for their bioactivities on 6 HCC cell lines and on dental pulp stem cells (DPSC) which differentiates into hepatocytes, and is used as a model for untransformed control cells. 3 of the chalcones (1, 9 and 11) were selected for further investigation due to their high cytotoxicity against liver cancer cells and compared to the other clinically established compounds. Chalcones did not show significant bioactivity ( $$\hbox {IC}_{50}>20\upmu \hbox {M}$$ ) on dental pulp stem cells. Cell cycle analysis revealed that these 3 chalcone-molecules induced SubG1/G1 arrest. Akt protein phosphorylation was inhibited by these molecules in PTEN deficient, drug resistant, mesenchymal like Mahlavu cells leading to the activation of p21 and the inhibition of NF $$ \kappa $$ B-p65 transcription factor. Hence the chalcones induced apoptotic cell death pathway through NF $$ \kappa $$ B-p65 inhibition. On the other hand, these molecules triggered p21 dependent activation of Rb protein and thereby inhibition of cell cycle and cell growth in liver cancer cells. Involvement of PI3K/Akt pathway hyperactivation was previously described in survival of liver cancer cells as carcinogenic event. Therefore, our results indicated that these chalcones can be considered as candidates for liver cancer therapeutics particularly when PI3K/Akt pathway involved in tumor development. - 29 March 2020
- Published by Taylor & Francis in Cranio®
- Vol. 40 (3) , 239-248
Effect of suprahyoid muscles on mouth opening with and without lateral pterygoid muscle: 3D inverse dynamic model analysis
Objective: To evaluate the contribution of suprahyoid muscles to mouth opening in different hyoid bone positions. Methods: The jaw-opening and closing movements were imposed on the 3D inverse dynamic jaw model with and without the lateral pterygoid muscle (LPM). The activation of the muscles was evaluated for eight different positions of the hyoid bone. Results: The muscles with 100% activation provided maximum mouth opening (MMO). When the hyoid bone was replaced, the muscles could achieve MMO at the 135º, 180º, and 225º points with the LPM. Mouth opening was estimated to be 36.8 mm in the absence of the LPM. A jaw opening greater than 36.8 mm was seen when the hyoid bone was repositioned at the 90º, 180º, and 135º points. Discussion: The contribution of suprahyoid muscles to mouth opening varies in different hyoid bone positions, with the inferior and anterior positions having a positive impact.
- 29 March 2020
- Published by Taylor & Francis in Cranio®
- Vol. 40 (3) , 239-248
Effect of suprahyoid muscles on mouth opening with and without lateral pterygoid muscle: 3D inverse dynamic model analysis
Objective: To evaluate the contribution of suprahyoid muscles to mouth opening in different hyoid bone positions. Methods: The jaw-opening and closing movements were imposed on the 3D inverse dynamic jaw model with and without the lateral pterygoid muscle (LPM). The activation of the muscles was evaluated for eight different positions of the hyoid bone. Results: The muscles with 100% activation provided maximum mouth opening (MMO). When the hyoid bone was replaced, the muscles could achieve MMO at the 135º, 180º, and 225º points with the LPM. Mouth opening was estimated to be 36.8 mm in the absence of the LPM. A jaw opening greater than 36.8 mm was seen when the hyoid bone was repositioned at the 90º, 180º, and 135º points. Discussion: The contribution of suprahyoid muscles to mouth opening varies in different hyoid bone positions, with the inferior and anterior positions having a positive impact.
- Open Access
- 1 January 2018
- Published by Medicina Oral, S.L. in Medicina Oral Patología Oral y Cirugia Bucal
- Vol. 23 (4) , E443-E448
Recurrence rate of odontogenic keratocyst treated by enucleation and peripheral ostectomy: Retrospective case series with up to 12 years of follow-up
Background: Odontogenic keratocysts have been reported with high recurrence rates in the literature so various treatment modalities from simple enucleation to resection have been performed to achieve the cure. The purpose of this retrospective study was to investigate the recurrence rate of odontogenic keratocysts (OKCs) treated by enucleation and peripheral ostectomy. Material and Methods: An electronic search of the database of the Hacettepe University, Faculty of Medicine, Department of Pathology, was undertaken to identify patients histologically diagnosed with OKCs treated at Department of Oral and Maxillofacial Surgery between 2001 and 2015. Results: In total, 81 patients were studied. The mean age at the time of diagnosis was 42 years, and the male: female ratio was 1:0.7. OKCs were located primarily in the posterior mandibular region (41%). Twenty-seven patients were re-examined to determine the recurrence rate. The mean follow-up period was 5 years (range, 1-12 years). The recurrence rate was 14.8%. The relationship between location of the lesion and recurrence was not statistically significant (p = 0.559). There was also no statistically significant relation between the recurrence rate and treatment option of teeth involved in the lesion (p = 0.579). Conclusions: The authors conclude that treatment of OKCs by enucleation with peripheral ostectomy is associated with minimal morbidity and is preferred over other aggressive treatment modalities. Meticulous radiographic examination and careful surgical resection may decrease the recurrence rate of OKCs.
- 1 January 2018
- Published by Medicina Oral, S.L. in Medicina Oral Patología Oral y Cirugia Bucal
- Vol. 23 (4) , E443-E448
Open AccessRecurrence rate of odontogenic keratocyst treated by enucleation and peripheral ostectomy: Retrospective case series with up to 12 years of follow-up
Background: Odontogenic keratocysts have been reported with high recurrence rates in the literature so various treatment modalities from simple enucleation to resection have been performed to achieve the cure. The purpose of this retrospective study was to investigate the recurrence rate of odontogenic keratocysts (OKCs) treated by enucleation and peripheral ostectomy. Material and Methods: An electronic search of the database of the Hacettepe University, Faculty of Medicine, Department of Pathology, was undertaken to identify patients histologically diagnosed with OKCs treated at Department of Oral and Maxillofacial Surgery between 2001 and 2015. Results: In total, 81 patients were studied. The mean age at the time of diagnosis was 42 years, and the male: female ratio was 1:0.7. OKCs were located primarily in the posterior mandibular region (41%). Twenty-seven patients were re-examined to determine the recurrence rate. The mean follow-up period was 5 years (range, 1-12 years). The recurrence rate was 14.8%. The relationship between location of the lesion and recurrence was not statistically significant (p = 0.559). There was also no statistically significant relation between the recurrence rate and treatment option of teeth involved in the lesion (p = 0.579). Conclusions: The authors conclude that treatment of OKCs by enucleation with peripheral ostectomy is associated with minimal morbidity and is preferred over other aggressive treatment modalities. Meticulous radiographic examination and careful surgical resection may decrease the recurrence rate of OKCs.
- 1 August 2017
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 45 (8) , 1158-1164
The effect of chronic dental inflammation on development of Stage 0 medication-related osteonecrosis of the jaw
- 1 August 2017
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 45 (8) , 1158-1164
The effect of chronic dental inflammation on development of Stage 0 medication-related osteonecrosis of the jaw
- 1 October 2015
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 44, e202
Keratocystic odontogenic tumor: the correlation between recurrence rate and conservative treatment approach
- 1 October 2015
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 44, e202
Keratocystic odontogenic tumor: the correlation between recurrence rate and conservative treatment approach